Real-world (RW) outcomes of second-line (2L) small cell lung cancer (SCLC) patients treated with lurbinectedin

被引：4
|
作者：
Estrin, A. [1 ]
Wang, X. [2 ]
Boccuti, A. [3 ]
Prince, P. [1 ]
Gautam, N. [1 ]
Rengarajan, B. [3 ]
Li, W. [2 ]
Lu, T. [3 ]
Cao, Y. [2 ]
Naveh, N. [2 ]
D'Agostino, R. [4 ]
Ben-Joseph, R. [3 ]
Ganti, A. K. [5 ]
机构：
[1] Aetion Inc, Sci, New York, NY USA
[2] Jazz Pharmaceut, Med Affairs, Philadelphia, PA USA
[3] Jazz Pharmaceut, Med Affairs, Palo Alto, CA USA
[4] Wake Forest Univ Sch Med, Biostat & Data Sci, Winston Salem, NC USA
[5] Univ Nebraska Med Ctr, VA Nebraska Western Iowa Hlth Care Syst, Nebraska Med Ctr, Omaha, NE USA
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1633
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1539P
引用
收藏
页码：S1250 / S1250
页数：1
相关论文
共 50 条
  • [1] Real-world outcomes with lurbinectedin in second-line and beyond for small cell lung cancer in Korea.
    Shim, Joosung Gabriel
    Lim, Sun Min
    Cho, Byoung Chul
    Hong, Min Hee
    Lee, Jii Bum
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 211 - 211
  • [2] Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer
    Desai, Aakash
    Smith, Caleb J.
    Ashara, Yash
    Orme, Jacob J.
    Zanwar, Saurabh
    Potter, Ashley
    Hocum, Craig
    Moffett, J. Nicole
    Schwecke, Anna J.
    Manochakian, Rami
    Lou, Yanyan
    Zhao, Yujie
    Ernani, Vinicius
    Savvides, Panos
    Molina, Julian
    Dimou, Anastasios
    Mansfield, Aaron S.
    Parikh, Kaushal
    Leventakos, Konstantinos
    CLINICAL LUNG CANCER, 2023, 24 (08) : 689 - +
  • [3] EFfectiveness and Safety Profile of Lurbinectedin in Second-Line Small Cell Lung Cancer: A Real-World Study
    Ganti, A. K.
    Allan, V.
    Merola, D.
    Estrin, A.
    Boccuti, A.
    Rengarajan, B.
    Baratta, C.
    Prince, P.
    Li, W.
    Cao, Y.
    D'Agostino, R. B., Jr.
    Poole, E. M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S378 - S379
  • [4] Real-World Effectiveness and Safety Profile of Lurbinectedin and Other Second-Line Treatments in Small Cell Lung Cancer
    Ganti, Apar Kishor
    Allan, Victoria
    Prince, Patricia
    Estrin, Adina
    Gautam, Nileesa
    Merola, Dave
    Boccuti, Anne
    Rengarajan, Badri
    Baratta, Cristina
    Li, Wenyan
    Cao, Yanyan
    Poole, Elizabeth M.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E50 - E51
  • [5] Real-World Outcomes with Lurbinectedin in Second Line and Beyond for Extensive Stage Small Cell Lung Cancer in Korea
    Shim, Joo Sung
    Kim, Youhyun
    Yuh, Taeho
    Lee, Jii Bum
    Kim, Hye Ryun
    Hong, Min Hee
    Cho, Byoung Chul
    Lim, Sun Min
    LUNG CANCER-TARGETS AND THERAPY, 2024, 15 : 149 - 159
  • [6] RESILIENT part 1: Pharmacokinetics of second-line (2L) liposomal irinotecan in patients with small cell lung cancer (SCLC)
    Ponce, S.
    Brendel, K.
    Spigel, D. R.
    Chen, Y.
    Jove Casulleras, M.
    Juan-Vidal, O.
    Rich, P.
    Hayes, T.
    Gutierrez Calderon, V.
    Bernabe Caro, R.
    Navarro, A.
    Dowlati, A.
    Zhang, B.
    Moore, Y.
    Kokhreidze, J.
    Pedret-Dunn, A.
    Paz-Ares, L.
    Bunn, P. A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1038 - S1039
  • [7] COST-EFFECTIVENESS MODELING OF LURBINECTEDIN AS A SECOND-LINE THERAPY IN PATIENTS WITH SMALL CELL LUNG CANCER (SCLC)
    Su, W.
    Rengarajan, B.
    Profant, D.
    Mayo, K.
    Groff, M.
    Tremblay, G.
    Ganti, A. K.
    VALUE IN HEALTH, 2023, 26 (06) : S87 - S87
  • [8] Real-world outcomes after second-line treatment in non-small cell lung cancer (NSCLC) patients treated with immunotherapy.
    Maramarelis, Melina Elpi
    Hwang, Wei-Ting
    Yang, Tu-Xiao
    Ciunci, Christine Agnes
    Singh, Aditi Puri
    Aggarwal, Charu
    Cohen, Roger B.
    Langer, Corey J.
    Mamtani, Ronac
    Bauml, Joshua
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Efficacy and safety of second-line (2L) therapy in patients with relapsed small cell lung cancer (SCLC): A systematic literature review (SLR).
    Nair, Abhishek A.
    Kwon, Christina S.
    Harricharan, Sharada
    Zhang, Xinke
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] OUTCOMES OF SMALL CELL LUNG CANCER (SCLC) PATIENTS TREATED WITH SECOND-LINE CHEMOTHERAPY (SL): A RETROSPECTIVE ANALYSIS OF 166 PATIENTS
    Garassino, M. C.
    Califano, R.
    Michetti, G.
    Borgonovo, K.
    Lo Dico, M.
    Fatigoni, S.
    Martelli, O.
    Ghidini, A.
    Bareggi, C.
    Torri, V.
    LUNG CANCER, 2009, 64 : S62 - S62
12345